An overview of the validation and qualification requirements introduced in the 2022 EU GMP Annex 1 revision, with a focus on ...
Successful partnership continues as bispecific antibody candidate moves to GMP manufacturing; project highlights Japan's advanced capabilities in ...
Also Announces Extension of IR Program VANCOUVER, BC / ACCESS Newswire / May 1, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company") is ...
High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...
Contamination control strategies define risk analysis, mitigation, and corrective actions to support sterility assurance.
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
Key market opportunities in the CDMO for formulations sector include increasing demand for custom peptide synthesis, ...
In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...
New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...
Creative Biogene, a frontrunner in biotechnology solutions, providing cost-effective consumables and reagents, focusing on first generation as well as next-generation sequencing and DNA fragment ...
Under the terms of the agreement, Emergent will provide end-to-end development and manufacturing services to SAB BIO that are compliant with current good manufacturing practices. These services will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results